The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
AstraZeneca vaccine can be used for over 65s and Covid variants, WHO says | France24 | The alarm was raised when a trial at Johannesburg's University of Witwatersrand concluded the AstraZeneca vaccine provided only "minimal" protection against mild to moderate Covid-19 caused by the variant. That was bad news for many poorer nations counting on the greater accessibility, affordability and logistical advantages offered by the AstraZeneca shot. But the WHO and its partners have cautioned against dismissing the vaccine, pointing to the small size and possibly problematic methodology of the South African study, insisting more data was needed.
The alarm was raised when a trial at Johannesburg's University of Witwatersrand concluded the AstraZeneca vaccine provided only "minimal" protection against mild to moderate Covid-19 caused by the variant. That was bad news for many poorer nations counting on the greater accessibility, affordability and logistical advantages offered by the AstraZeneca shot.
But the WHO and its partners have cautioned against dismissing the vaccine, pointing to the small size and possibly problematic methodology of the South African study, insisting more data was needed.
Dr @MoetiTshidi discusses South Africa's decision to temporarily pause planned roll out of the Oxford-AstraZeneca #COVID19 vaccine. This follows a new study showing it has limited efficacy against mild/moderate cases caused by the #SouthAfrica variant. [_link]— WHO African Region (@WHOAFRO) February 9, 2021
Dr @MoetiTshidi discusses South Africa's decision to temporarily pause planned roll out of the Oxford-AstraZeneca #COVID19 vaccine. This follows a new study showing it has limited efficacy against mild/moderate cases caused by the #SouthAfrica variant. [_link]
South Africa looking at ways to use AstraZeneca vaccine, advisers say ... their use would be suspended until more evidence was available on whether the vaccine protects against severe COVID-19 from the 501Y.V2 variant, which is more contagious and currently accounts for more than 90% of the country's cases.
... their use would be suspended until more evidence was available on whether the vaccine protects against severe COVID-19 from the 501Y.V2 variant, which is more contagious and currently accounts for more than 90% of the country's cases.
by Luis de Sousa - Feb 28 1 comment
by IdiotSavant - Feb 28
by Oui - Mar 1
by Frank Schnittger - Feb 23 15 comments
by Oui - Feb 22 19 comments
by Oui - Feb 25
by Frank Schnittger - Feb 20 16 comments
by gmoke - Feb 14 2 comments
by gmoke - Mar 1
by Luis de Sousa - Feb 281 comment
by Oui - Feb 2827 comments
by Frank Schnittger - Feb 2315 comments
by Oui - Feb 2219 comments
by Frank Schnittger - Feb 2016 comments
by Oui - Feb 2021 comments
by Frank Schnittger - Feb 1914 comments
by Oui - Feb 197 comments
by Oui - Feb 18
by Oui - Feb 1787 comments
by Oui - Feb 168 comments
by Frank Schnittger - Feb 1523 comments
by gmoke - Feb 142 comments
by Frank Schnittger - Feb 1413 comments
by Oui - Feb 145 comments
by Oui - Feb 1245 comments